Combined immunotherapeutic effect of Leishmania-derived recombinant aldolase and Ambisome against experimental visceral leishmaniasis

Background: Available therapeutics for visceral leishmaniasis (VL), a deadly parasitic infection, are usually associated with inadequate efficacy and adverse aftereffects. Further, the primary site of Leishmania parasite are host macrophages resulting in compromised immunity; ensuing marked T-cell i...

Full description

Bibliographic Details
Main Authors: Keerti, Narendra Kumar Yadav, Sumit Joshi, Sneha Ratnapriya, Amogh Anant Sahasrabuddhe, Anuradha Dube
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Journal of Microbiology, Immunology and Infection
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118222000949